Retinoids in cancer chemoprevention - Clinical trials with the synthetic analogue fenretinide

被引：34

作者：

Costa, A

DePalo, G

Decensi, A

Formelli, F

Chiesa, F

Nava, M

Camerini, T

Marubini, E

Veronesi, U

机构：

[1] IST NAZL TUMORI,I-20133 MILAN,ITALY

[2] IST NAZL RIC CANC,I-16132 GENOA,ITALY

来源：

CANCER PREVENTION: FROM THE LABORATORY TO THE CLINIC: IMPLICATIONS OF GENETIC, MOLECULAR, AND PREVENTIVE RESEARCH | 1995年 / 768卷

关键词：

D O I：

10.1111/j.1749-6632.1995.tb12118.x

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：148 / 162

页数：15

共 50 条

[1]

BADALAMENT RA, 1986, CANCER-AM CANCER SOC, V58, P2751, DOI 10.1002/1097-0142(19861215)58:12<2751::AID-CNCR2820581233>3.0.CO

[2]

2-E

[3] CHANGES IN PLASMA-LIPIDS AND LIPOPROTEINS DURING ISOTRETINOIN THERAPY FOR ACNE [J].

BERSHAD, S ;

RUBINSTEIN, A ;

PATERNITI, JR ;

LE, NA ;

POLIAK, SC ;

HELLER, B ;

GINSBERG, HN ;

FLEISCHMAJER, R ;

BROWN, WV .

NEW ENGLAND JOURNAL OF MEDICINE, 1985, 313 (16) :981-985

[4]

BOONE CW, 1990, CANCER RES, V50, P2

[5] AN OVERVIEW OF THE RETINOIDS [J].

BOYD, AS .

AMERICAN JOURNAL OF MEDICINE, 1989, 86 (05) :568-574

[6]

BUNK M J, 1985, Nutrition and Cancer, V7, P105

[7]

CHIESA F, 1990, ARCH OTOLARYNGOL, V116, P177

[8]

CHIESA F, 1992, ORAL ONCOL, V28B, P97

[9] TOLERABILITY OF THE SYNTHETIC RETINOID FENRETINIDE (HPR) [J].

COSTA, A ;

MALONE, W ;

PERLOFF, M ;

BURANELLI, F ;

CAMPA, T ;

DOSSENA, G ;

MAGNI, A ;

PIZZICHETTA, M ;

ANDREOLI, C ;

DELVECCHIO, M ;

FORMELLI, F ;

BARBIERI, A .

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1989, 25 (05) :805-808

[10]

COSTA A, 1992, BREAST, V1, P119

← 1 2 3 4 5 →